text: If mucormycosis is suspected, prompt amphotericin B therapy should be administered due to the rapid spread and mortality rate of the disease. Amphotericin B (which works by damaging the cell walls of the fungi) is usually administered for a further 4-6 weeks after initial therapy begins to ensure eradication of the infection. Posaconazole has been shown to be effective against mucormycosis, perhaps more so than amphotericin B, but has not yet replaced it as the standard of care. After administration the patient must then be admitted to surgery for removal of the "fungus ball". The disease must be monitored carefully for any signs of reemergence. Treatment for skin lesions is traditionally with potassium iodide, but itraconazole has also been used successfully.
option_0: Zygomycosis medical therapy
option_1: Actinomycosis medical therapy
option_2: Sporotrichosis medical therapy
option_3: Anthrax medical therapy
option_4: Mucormycosis medical therapy
option_5: Blastomycosis medical therapy
option_6: Yaws medical therapy
option_7: Paracoccidioidomycosis medical therapy